cd138 car-t cells
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2018 (NCT03473496)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Syndecan-1Immunity, passive
SDC1 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03672318 | Phase 1 | Oct 31, 2018 | University of North Carolina at Chapel Hill |
| NCT03473496 | N/A | Mar 1, 2018 | Southern Medical University, Sun Yat-Sen University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Southern Medical University | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of North Carolina at Chapel Hill | Academic/Hospital | 1 | 1 | 1 | 2018 |
3 organizations
Page 1 / 1